EUVIMEDEUVIMED entdecken
Crossref

Recent Advances and Clinical Value of Anlotinib Combined with Immunotherapy in Non-Small Cell Lung Cancer

雅辰 高

Advances in Clinical Medicine · 2026 · 16 (04) · 4521-4531

DOI: 10.12677/acm.2026.1641723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Clinical Medicine, 2026. Verfasst von 雅辰 高. Die Arbeit nennt 41 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

高, 雅. (2026). Recent Advances and Clinical Value of Anlotinib Combined with Immunotherapy in Non-Small Cell Lung Cancer. Advances in Clinical Medicine, 16(04), 4521-4531. https://doi.org/10.12677/acm.2026.1641723

Vancouver

高 雅. Recent Advances and Clinical Value of Anlotinib Combined with Immunotherapy in Non-Small Cell Lung Cancer. Advances in Clinical Medicine. 2026;16(04):4521-4531. doi:10.12677/acm.2026.1641723

BibTeX
@article{2026,
  author = {高, 雅辰},
  title = {Recent Advances and Clinical Value of Anlotinib Combined with Immunotherapy in Non-Small Cell Lung Cancer},
  journal = {Advances in Clinical Medicine},
  year = {2026},
  volume = {16},
  number = {04},
  pages = {4521--4531},
  doi = {10.12677/acm.2026.1641723}
}
Kostenlos starten →